Logo for IDEAYA Biosciences Inc

IDEAYA Biosciences Investor Relations Material

Latest events

Logo for IDEAYA Biosciences Inc

Study Update

IDEAYA Biosciences
Logo for IDEAYA Biosciences

Study Update

23 Sep, 2024
Logo for IDEAYA Biosciences

Q2 2024

6 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from IDEAYA Biosciences Inc

Access all reports
IDEAYA Biosciences Inc. is a clinical-stage biotechnology firm primarily engaged in the discovery and development of precision medicine therapeutics for cancer patients. The company's research focuses on synthetic lethality, an innovative class of precision medicine targets, aiming to produce therapeutics that are first-in-class and/or best-in-class. IDEAYA Biosciences leverages molecular diagnostics to select patient populations for its targeted therapies, emphasizing an integrated approach to the discovery and development of biomarkers and therapeutics. This approach spans early discovery through clinical development, targeting unmet needs in cancer treatment. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.